November 6, 2024- Owens & Minor reported financial results for the third quarter ended September 30, 2024. Consolidated revenue of $2.7 billion in the third quarter, representing year-over-year growth of 5%. GAAP Net loss of $(13) million or $(0.17) per share, and adjusted earnings per share of $0.42 in the third quarter. Adjusted EBITDA of $142 million in the third quarter, representing year-over-year growth of 5%, and the company had a $198 million in total debt reduction in the third quarter.
Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor, said “our third quarter results demonstrated our ability to deliver on our commitments both near-term as well as on our strategic initiatives. Our Patient Direct segment continues to perform well in the growing home-based care space while we continue investing to support long-term profitable growth. In our Products & Healthcare Services segment, we continue to see solid top-line results, especially within our Medical Distribution division supported by recent wins and deepened relationships with our existing customers.”